# Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

> **NCT06577311** · PHASE2 · RECRUITING · sponsor: **The Center for Clinical and Cosmetic Research** · enrollment: 20 (estimated)

## Conditions studied

- Cutaneous Squamous Cell Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** Aminolevulinic acid hydrochloride 10% topical gel with Red Light

## Key facts

- **NCT ID:** NCT06577311
- **Lead sponsor:** The Center for Clinical and Cosmetic Research
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-14
- **Primary completion:** 2025-08
- **Final completion:** 2025-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06577311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06577311, "Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06577311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*